1.71
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Marker Therapeutics Inc | MRKR | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.00 | 0.0% | 1.71 | 20:00:00 |
| Close Price | Low Price | High Price | Open Price | Previous Close |
|---|---|---|---|---|
| 1.7117 | 1.66 | 1.75 | 1.75 | 1.71 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 1.59 | 1.74 | 0.15 | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 960 | 183,290 | $ 1.73 | $ 316,295 | 235,325 | 1.33 - 6.22 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:24:49 | formt | 1,062 | $ 1.71 | USD |
Marker Therapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 79.72M | 46.62M | 27.26M | $ 213.19k | $ - | -0.47 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Marker Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MRKR Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.55 | 1.75 | 1.46 | 1.60 | 256,792 | 0.16 | 10.32% |
| 1 Month | 1.88 | 1.94 | 1.436 | 1.64 | 225,943 | -0.17 | -9.04% |
| 3 Months | 2.02 | 2.23 | 1.436 | 1.88 | 251,669 | -0.31 | -15.35% |
| 6 Months | 1.94 | 3.22 | 1.436 | 2.15 | 381,433 | -0.23 | -11.86% |
| 1 Year | 6.08 | 6.22 | 1.33 | 2.61 | 349,300 | -4.37 | -71.88% |
| 3 Years | 10.01 | 10.25 | 1.33 | 4.50 | 374,304 | -8.30 | -82.92% |
| 5 Years | 10.01 | 10.25 | 1.33 | 4.50 | 374,304 | -8.30 | -82.92% |
Marker Therapeutics Description
| Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and innovative peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets. It is also developing peptide-based immunotherapeutic vaccines for the treatment of metastatic solid tumors, as well as PolyStart. |
